Pharmaceuticals

Plant-based Expression Systems Market Size, Share & Trends Analysis Report By Product (Biosimilars, Cell Therapies, Gene Therapies, Monoclonal Antibodies, Vaccines, Others), By Plant, By Expression system, By Type of Service, By Region, And Segment Forecasts, 2025-2034

Global Plant-based Expression Systems Market Size is valued at USD 2.2 Billion in 2024 and is predicted to reach USD 5.4 Billion by the year 2034 at a 9.4% CAGR during the forecast period for 2025-2034. In recent years, the plant-based expression system has gained significant attention for its characteristics of high compatibility with culture media, safety, and low cost. Plant expression systems are a practical option for producing antibodies, ...

Report ID: 1292  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180

3D Printing in Veterinary Medicine Market Size, Share & Trends Analysis Report By Product (3D Printed Masks, 3D Printed Animal Prosthetics & Orthodontics, 3D Printed Implants, 3D Printed Anatomical Model), By Material Type, By End-user, By Region, And Segment Forecasts, 2025-2034

Global 3D Printing in Veterinary Medicine Market Size is valued at USD 113.6 Million in 2024 and is predicted to reach USD 291.3 Million by the year 2034 at an 10.0% CAGR during the forecast period for 2025-2034. Over the course of the forecast period, an increase in the need for organ transplants is anticipated to drive expansion in the global market for 3D printed medical devices. Rising research and development spending, particularly in devel...

Report ID: 1561  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180

Maternal Mental Health Market Size, Share & Trends Analysis Report By Disease Indication (Postpartum Depression, Dysthymia, Pregnancy and Postpartum General Anxiety, Pregnancy and Postpartum OCD, Birth-Related PTSD, Others), By Therapy, By Region, And By Segment Forecasts, 2025-2034

Maternal Mental Health Market Size is valued at USD 9.88 Bn in 2024 and is predicted to reach USD 100.38 Bn by the year 2034 at a 26.2% CAGR during the forecast period for 2025-2034. The maternal mental health market is a subset of the healthcare business that focuses on diagnosing, treating, and preventing mental health disorders in pregnant women and new mothers. Perinatal depression and anxiety, as well as postpartum depression and psychosi...

Report ID: 2096  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 179

Spatial Omics Solutions Market Size, Share & Trends Analysis Report By Solution Type (Instruments, Consumables, Services), By Sample Analyzed (DNA, RNA, Protein), By Application, By End-User, By Region, And By Segment Forecasts, 2025-2034

Global Spatial Omics Solutions Market Size is valued at USD 457.7 Million in 2024 and is predicted to reach USD 1233.9 Million by the year 2034 at a 10.5% CAGR during the forecast period for 2025-2034. Spatial omics consists of Proteomics, epigenomics, transcriptomics, Genomics, metabolomics and lipidomic. The field of spatial omics combines molecular analysis with geographical information concerning the location of a cell inside a tissue. As ...

Report ID: 1352  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 175

Polycystic Ovary Syndrome (PCOS) Treatment Market Size, Share & Trends Analysis Report By Drug Class / Therapy Type (Insulin-Sensitizing Agents, Oral Contraceptives, Anti-Androgens, Anti-Obesity Drugs, Others (Combination / Adjunct Therapies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies / Drug Stores, Online Pharmacies), By Route of Administration (Oral Drugs, Injectable Drugs), By Region and By Segments Forecasts, 2025-2034

Global Polycystic Ovary Syndrome (PCOS) Treatment Market Size is valued at USD 4.5 Bn in 2024 and is predicted to reach USD 8.0 Bn by the year 2034 at a 6.1% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The polycystic ovarian syndrome treatment market experienced growth due to a rise in PCOS prevalence and an increase in the patient population. Research and development in PCOS also assi...

Report ID: 1455  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 175

Flow Cytometry Services Market Size, Share & Trends Analysis Report By Accreditation Type (Government, Third-Party Accreditations), By Service Type (General Flow Cytometric Services, Analysis based Flow Cytometric Services, Other types of Flow Cytometric Services), By Region, And Segment Forecasts, 2025-2034

Global Flow Cytometry Services Market Size is valued at USD 3.2 Billion in 2024 and is predicted to reach USD 7.7 Billion by the year 2034 at a 9.3% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report:   This market growth is being attributed to the increasing prevalence of HIV/AIDS and cancer, as well as new technological advancements in flow cytometry instruments. The growing uses o...

Report ID: 1209  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180

Genetic Screening Testing for Preventive Health Market Size, Share & Trends Analysis Report By test type (Carrier Screening Tests (Expanded Carrier Screening, Targeted Carrier Screening), Non-Invasive Prenatal Tests, Preimplantation Genetic Testing, And Newborn Screening), Technology (NGS, Microarray, PCR, FISH), Application (Oncology, Cardiovascular Diseases, Reproductive Health, Neurodegenerative Health, Rare Diseases), And End-User (Hospitals And Diagnostic Laboratories, Dtc Companies, Genetic Counselling Services), By Region, And By Segment Forecasts, 2025-2034.

Genetic Screening Testing for Preventive Health Market is predicted to grow at a 11.8% CAGR during the forecast period for 2025-2034. Analyzing a person's genetic composition to forecast their risk of contracting specific diseases or ailments in the future is known as genetic screening tests for preventative health. These tests are intended to detect genetic susceptibilities to several illnesses, including diabetes, cancer, heart disease, and ...

Report ID: 2956  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180

Dopamine Agonist Market Size, Share & Trends Analysis Report By Drug (Ergot Alkaloids, Non-Ergot Dopamine Agonists), By Application (Parkinson's Disease, Restless Legs Syndrome (RLS), Hyperprolactinemia, Others), By Route of Administration (Oral, Injectable, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Pharmacies), By Region, And By Segment Forecasts, 2025-2034.

Dopamine Agonist Market Size is valued at USD 1.4 billion in 2024 and is predicted to reach USD 2.9 billion by the year 2034 at a 7.4% CAGR during the forecast period for 2025-2034. Dopamine agonists are a class of drugs that imitate the effects of dopamine by activating dopamine receptors in the brain. They are mostly used to treat illnesses where dopamine plays a part in the disease process, such as Parkinson's disease, where dopamine levels...

Report ID: 2958  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180

Virtual Biopsy Market Size, Share & Trends Analysis Report By Therapeutic Area (Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders), Type Of Cancer, Type Of Imaging Technology, And End-user, By Region, And By Segment Forecasts, 2025-2034

Global Virtual Biopsy Market is valued at USD 0.8 Billion in 2024 and is predicted to reach USD 2.1 Billion by the year 2034 at a 12.3% CAGR during the forecast period for 2025-2034.  A virtual biopsy is a non-invasive diagnostic method that offers a safer substitute for conventional tissue biopsy methods by examining tissue properties and identifying anomalies using cutting-edge imaging technology, such as MRI or CT scans, in conjunction...

Report ID: 2933  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180

Inhalable Biologics Market Size, Share & Trends Analysis Report By Type (Peptides And Proteins, Vaccines, Monoclonal Antibodies, RNAi-Based Therapeutics), Application (Respiratory Diseases, Diabetes, Cancer), Dosage Form (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers), And Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies), By Region, And By Segment Forecasts, 2025-2034.

Global Inhalable Biologics Market is valued at USD 3.8 Billion in 2024 and is predicted to reach USD 17.2 Billion  by the year 2034 at an 19.4% CAGR during the forecast period for 2025-2034. Inhalable biologics are biologic drugs that are breathed in and given through the lungs. These drugs include proteins, antibodies, and vaccines. The market is growing due to factors such as increasing patient desire for self-administration, quicker dr...

Report ID: 2935  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180